Skip to Main Content

Paper Details

Tim-3 mediates T cell trogocytosis to limit antitumor immunity.
J Clin Invest
19
2022
), APCs, CD8, CD8+, CD8+ T cells, CD8+ TILs, PD-1, T cell, T cell immunoglobulin mucin domain-containing protein 3, TILs, Tim-3, Tim-3+ APCs, antigen-presenting cells, cancer, cell, dendritic cells, human, human programmed cell death 1-positive (PD-, human programmed cell death 1-positive (PD-1+) Tim-3+CD8+ tumor-infiltrating lymphocytes, melanoma, mouse, patients, phosphatidylserine, programmed, tumor, tumor antigen-specific CD8+ T, tumor antigen-specific CD8+ T cells, tumor peptide-major histocompatibility complexes
Author NameAffiliation
Simon C WatkinsUniversity of Pittsburgh
Simon C WatkinsUniversity of Pittsburgh
Cindy SanderDepartment of Medicine and UPMC Hillman Cancer Center.
John M KirkwoodDepartment of Medicine and UPMC Hillman Cancer Center.
Marcus BosenbergYale University School of Medicine
Arvind Rajpal
Pavel Strop
  • 1 - 7

Datasets

Release 1.2